Clinical Trial: Eplerenone for the Treatment of Central Serous Chorioretinopathy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Eplerenone for the Treatment of Central Serous Chorioretinopathy
Brief Summary: To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .
Detailed Summary: To evaluate the effect of oral eplerenone compared to placebo in patients with central serous chorioretinopathy (CSCR) on sub-foveal (small part of retina) fluid using optical coherence tomography (OCT).
Sponsor: Wills Eye
Current Primary Outcome: Absence of sub-foveal (retinal) fluid based on spectral domain optical coherence tomography (OCT) measurement. [ Time Frame: At 1 month in acute CSCR and 2 months in chronic CSR patients ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Mean change in subfoveal fluid height based on OCT measurement [ Time Frame: Month 1 for acute CSCR patients, Month 2 in chronic CSCR patients ]
Original Secondary Outcome: Same as current
Information By: Wills Eye
Dates:
Date Received: November 15, 2013
Date Started: October 2013
Date Completion:
Last Updated: January 9, 2017
Last Verified: January 2017